- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07518888
Steroidændringer induceret af motion i aktiv overvågning af prostatakræft (ESCAPE)
Træningsinducerede steroidforandringer i aktiv overvågning ved prostatakræft
The purpose of this research study is to understand how a short session of a home-based bodyweight high-intensity interval training (HIIT) affects steroid hormone levels in men on active surveillance for low-grade prostate cancer.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Nima Sharifi, MD
- Telefonnummer: 305-243-1350
- E-mail: nimasharifi@miami.edu
Undersøgelse Kontakt Backup
- Navn: Elena Cortizas, MS
- Telefonnummer: (305) 243-3593
- E-mail: ecortizas@med.miami.edu
Studiesteder
-
-
Florida
-
Miami, Florida, Forenede Stater, 33141
- Rekruttering
- University of Miami Hospitals and Clinics
-
Kontakt:
- Elena Cortizas, MS
- Telefonnummer: (305) 243-3593
- E-mail: ecortizas@med.miami.edu
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Males 18 to 80 years old
- Diagnosis of localized prostate cancer
- Currently under active surveillance
- Ability to perform moderate-to-high intensity physical activity as demonstrated by self-assessment using the Physical Activity Readiness Questionnaire (PAR-Q+)
- Able to independently perform activities of daily living, without limitations in mobility
- Ability to read, write, speak, and understand English
- Able and willing to sign consent and comply with study requirements
Exclusion Criteria:
- Males currently receiving treatment for prostate cancer
- Diagnosis of metastatic prostate cancer
- Individuals with medical conditions contraindicating exercise
- Uncontrolled cardiovascular or circulatory diseases, hypertension, and diabetes, as determined by the study doctor or treating physician
- Ongoing use of medications affecting steroid metabolism
- Unable to sign consent and/or comply with study requirements
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Home-Based High Intensity Interval Training (HIIT) Exercise Session + Saliva Collection
Participants will complete a single supervised, online high intensity interval training (HIIT) exercise session performed at a moderate-to-high intensity lasting approximately 20 minutes. Saliva samples will be collected immediately prior to exercise, immediately following exercise (0-5 minutes), and 15-20 minutes post-exercise. |
Participants will complete a single supervised, online high intensity interval training (HIIT) exercise session lasting approximately 20 minutes. The exercise protocol consists of 3 rounds of moderate to high intensity bodyweight exercises, including movements such as hip thrusts, lateral squats, wall pushups, lat pull downs, lunges, and jumping jacks. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Protocol Completion Rate
Tidsramme: From enrollment through completion of all study procedures (up to Day 1)
|
Protocol Completion Rate is defined as the proportion of enrolled participants who complete both the supervised home-based HIIT exercise session and return all scheduled saliva samples to the laboratory. |
From enrollment through completion of all study procedures (up to Day 1)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Acceptability of the Exercise and Saliva Collection Protocol
Tidsramme: Immediately after protocol completion (Day 1)
|
Acceptability will be assessed using a participant-reported questionnaire adapted from the Theoretical Framework of Acceptability (TFA). The questionnaire evaluates acceptability across seven domains: affective attitude, burden, perceived effectiveness, ethicality, intervention coherence, opportunity costs, and self-efficacy. Each domain is assessed using 1-2 items rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Domain scores are averaged, and an overall Acceptability Index score is calculated, with higher scores indicating greater acceptability. |
Immediately after protocol completion (Day 1)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Nima Sharifi, MD, University of Miami
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Genitale sygdomme
- Genitale neoplasmer, mandlige
- Urogenitale neoplasmer
- Neoplasmer efter sted
- Neoplasmer
- Kønssygdomme, mandlige
- Prostatasygdomme
- Mandlige urogenitale sygdomme
- Opførsel
- Prostatiske neoplasmer
- Motorisk aktivitet
- Motorisk aktivitet
- Bevægelse
- Muskuloskeletale fysiologiske fænomener
- Muskuloskeletale og neurale fysiologiske fænomener
- Fysisk konditionering, menneske
- Øvelse
- Intervaltræning med høj intensitet
Andre undersøgelses-id-numre
- 20251282
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .